언어선택 ENG
KOR ENG
전체메뉴
전체메뉴 닫기

IMB-202

Innovative Medicines based on
ImmunoModulatory Biologics

  • President(CEO) : Gyongsik Ha
  • 260, Changnyong-daero, Yeongtong-gu, Suwon-si, Gyeonggi-do, Republic of Korea